Postural Instability Is Greater in Men with Type 2 Diabetes after Exertional Heat Stress.

Med Sci Sports ExercMay 1, 2026 (epub)
Clinical ResearchEndocrinologyOpen access

Jericho Wee, Stesha Low, Xiang Ren Tan et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial investigated the effects of exertional heat stress on postural stability in middle-aged men with and without type 2 diabetes (T2D). The study found that men with T2D exhibited significantly greater postural instability after exercise in warm conditions compared to cool conditions, with anteroposterior center of pressure excursions increasing by 9 mm and total COP excursion by 126 mm in warm conditions.

Key findings

  • Men with T2D had a 9 mm greater anteroposterior COP excursion in warm conditions compared to cool.
  • Total COP excursion increased by 126 mm in men with T2D after exercise in warm conditions.
  • COP mean velocity was 5 mm/s higher in men with T2D in warm conditions compared to cool.

Why it matters

Understanding the impact of heat stress on postural stability in individuals with T2D is crucial for preventing falls and heat-related illnesses during exercise, particularly in warm environments.

Source

PubMed · PMID 42081289Free full text on PubMed Central

Published in Med Sci Sports Exerc. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Endocrinology

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.